- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06911398
AMIE's Clinical Conversational Abilities in an Urgent Care Setting
A Prospective Cohort Study of the Articulate Medical Intelligence Explorer's Ability to Take an Initial Triage History From Patients Prior to an Urgent Care Visit
The purpose of this study is to determine the feasibility of a conversational artificial intelligence (AI) system to have a meaningful clinical conversation with a patient prior to an urgent care visit with their primary care physician. In this study, patients who are seeking an urgent care visit (that is, any type of medical visit with their primary care provider for a new complaint) will first have a conversation with an AI system. This interaction with the AI system will happen less than a week before their visit with their physician, and will be supervised by an independent physician who will interrupt in case there are any concerns about patient safety. After the interaction, a summary of the conversation will be sent to the patient's PCP, who will review prior to the in-person visit.
The researchers will investigate:
- Patient views on the AI system
- PCP views on the AI system
- Overall safety, as measured by the physician safety supervisor
- Quality of clinical conversations, measured by standardized rubrics
- Quality of diagnostic and management plans generated by the AI; these will not be shared with the patient or physician, but will be generated after the fact and compared with the actual diagnosis and management plan.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Beth Israel Deaconess Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age > 18
- English included as a primary language in the electronic health record
- Patient is seeking episodic (urgent) care at HCA
Exclusion Criteria:
- Age < 18
- English not listed as a primary language in the electronic health record
- Visit reason is related to pregnancy
- Visit reason is a psychiatric concern
- Visit is to establish care, or for follow-up care
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Urgent care patients
|
AMIE is an AI system for having clinical conversations with patients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Chat terminations
Time Frame: Day 1
|
The researchers will collect the number of interruptions by the safety supervisor in response to safety concerns.
There are four pre-specified interruption criteria; the researchers will connect the total number in each category, as well as a qualitative description of the type of error.
|
Day 1
|
|
Patient-centered evaluation of clinical dialogue
Time Frame: Day 3
|
The researchers will use the General Medical Council Patient Questionnaire (GMCPQ) standardized rubric to rate the quality of clinical dialogue.
|
Day 3
|
|
Clinical skills-based assessment of clinical dialogue
Time Frame: Day 3
|
The researchers will use the Practical Assessment of Clinical Examination Skills (PACES) standardized rubric to rate the quality of clinical dialogue.
|
Day 3
|
|
Communication skills evaluation of clinical dialogue
Time Frame: Day 3
|
The researchers will use the Patient-Centered Communication Best Practice (PCCBP) standardized rubric to rate the quality of clinical dialogue.
|
Day 3
|
|
Patient satisfaction pre-AMIE encounter
Time Frame: Day 1
|
Patients will receive a pre-AMIE encounter questionnaire.
|
Day 1
|
|
Patient satisfaction post-AMIE encounter
Time Frame: Day 1
|
Patients will receive a post-AMIE encounter questionnaire.
|
Day 1
|
|
PCP satisfaction
Time Frame: Day 3
|
The researchers will collect a post-encounter questionnaire from the patient's PCP, asking about views on AI in healthcare and how AMIE interaction may have changed the in-person visit.
|
Day 3
|
|
Patient satisfaction post-PCP encounter
Time Frame: Day 3
|
Patients will receive a post-PCP encounter questionnaire.
|
Day 3
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Semi-structured interviews of patients
Time Frame: Up to 8 weeks
|
The researchers will perform semi-structured interviews of select patients participating in the study.
|
Up to 8 weeks
|
|
Diagnostic accuracy
Time Frame: Up to 4 weeks
|
The researchers will compare AMIE's differential diagnosis to the final diagnosis.
|
Up to 4 weeks
|
|
Management plan quality
Time Frame: Up to 4 weeks
|
The researchers will compare AMIE's management plan to the final management plan using the Management Reasoning Essential Key Features (MXEKF) rubric.
|
Up to 4 weeks
|
|
Semi-structured interviews of PCPs
Time Frame: Up to 8 weeks
|
The researchers will complete semi-structured interviews with all of the PCPs participating in the study.
|
Up to 8 weeks
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2024P000095
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Clinical Reasoning
-
King's College LondonGuy's and St Thomas' NHS Foundation TrustNot yet recruitingRehabilitation | Clinical Reasoning | Medical Record Documenation
-
Tung Wah CollegeRecruitingSatisfaction | Problem-solving | Clinical ReasoningHong Kong
-
Tongmyong UniversityCompletedCommunication | Clinical Reasoning | Development, HumanKorea, Republic of
-
Alexandria UniversityCompletedArtificial Intelligence | Nursing Education | Clinical Reasoning | Clinical Decision-Making | Electrocardiogram Interpretation | Cardiovascular CareEgypt
-
Gazi UniversityCompletedMedical Education | Clinical Reasoning | Feedback | Artificial Intelligence (AI)Turkey
-
Istanbul Medipol University HospitalNot yet recruitingClinical Reasoning | Physiotherapy and Rehabilitation | Student Education | Simulation Based Learning
-
Marmara UniversityHealth Institutes of TurkeyCompletedClinical Reasoning | Self-efficacyTurkey
-
Fenerbahce UniversityNot yet recruitingClinical Reasoning | Quality of Nursing Care | Critical Thinking in Nursing | Pediatric Nursing PracticeTurkey
-
Suleyman Demirel UniversityCompletedNursing Students | Health Diagnosis Skills | CORE | Clinical Oriented Reasoning ExamTurkey
-
Akdeniz UniversityNot yet recruitingNursing Education | Clinical Reasoning | AI (Artificial Intelligence) | OSCE (Objective Structured Clinical Examination) | Nursing Skills | AI Chatbot | IM InjectionTurkey (Türkiye)
Clinical Trials on Articulate Medical Intelligence Explorer (AMIE)
-
Stanford UniversityGoogle LLC.RecruitingGenetic Disease | Cardiomyopathy | Cardiology | Hypertrophic Cardiomyopathy (HCM)United States
-
Huashan HospitalRecruitingArtificial Intelligence | Respiratory Infectious Diseases | Medical ImagingChina
-
Montreal Heart InstituteMontefiore Medical Center; Unity Health Toronto; Pie Medical Imaging; Universitätsklinikum... and other collaboratorsRecruitingHeart Valve Disease | TAVI | Mitraclip | M-TEER | TTVI | TMVI | T-TEER | TriClipFrance, Germany, United States, Canada, Italy
-
Yonsei UniversityRecruitingAtrial FibrillationKorea, Republic of
-
Outcome ReaAssistance Publique - Hôpitaux de Paris; University Hospital, Clermont-Ferrand and other collaboratorsRecruitingCatheter InfectionFrance
-
Research and Practical Clinical Center for Diagnostics...Active, not recruitingTuberculosis, PulmonaryRussian Federation
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, France, Denmark, Sweden, Netherlands, Belgium, Finland, Macedonia, The Former Yugoslav Republic of, Norway, Israel, Spain, Croatia, Slovenia, United Kingdom, Switzerland, Ireland
-
Thammasat UniversityCompletedKnee OsteoarthritisThailand
-
National Cancer Institute (NCI)WithdrawnRecurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Fallopian Tube Undifferentiated Carcinoma | Recurrent Ovarian Clear Cell Adenocarcinoma | Recurrent Ovarian Undifferentiated Carcinoma and other conditions